WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009061830) METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/061830    International Application No.:    PCT/US2008/082495
Publication Date: 14.05.2009 International Filing Date: 05.11.2008
IPC:
A61K 31/06 (2006.01), A61K 38/00 (2006.01), A61K 38/18 (2006.01), A61K 39/00 (2006.01), A61P 9/10 (2006.01), A61P 35/00 (2006.01), A61P 27/00 (2006.01)
Applicants: MASSACHUSETTS EYE & EAR INFIRMARY [US/US]; 243 Charles Street 8th Floor Boston, MA 02114 (US) (For All Designated States Except US).
HAFEZI-MOGHADAM, Ali [DE/US]; (US) (For US Only)
Inventors: HAFEZI-MOGHADAM, Ali; (US)
Agent: WILSON, Daniel, A.; Goodwin Procter LLP Exchange Place Boston, MA 02109 (US)
Priority Data:
60/985,848 06.11.2007 US
Title (EN) METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITOR
(FR) MÉTHODES ET COMPOSITIONS POUR TRAITER DES TROUBLES ASSOCIÉS À L'ANGIOGENÈSE À L'AIDE D'UN INHIBITEUR DE LA PROTÉINE-1 D'ADHÉSION VASCULAIRE (VAP-1)
Abstract: front page image
(EN)The invention relates generally to methods and compositions for treating conditions associated with angiogenesis, and, more specifically, the invention relates to methods and compositions for treating conditions associated with angiogenesis using vascular adhesion protein- 1 (VAP-1) inhibitors. The invention also relates to methods and compositions for treating conditions associated with lymphangiogenesis using VAP-1 inhibitors.
(FR)L'invention porte en général sur des méthodes et des compositions permettant de traiter des troubles associés à l'angiogenèse, et plus spécifiquement sur des méthodes et des compositions permettant de traiter des troubles associés à l'angiogenèse à l'aide d'un inhibiteur de la protéine-1 d'adhésion vasculaire (VAP-1). L'invention concerne également des méthodes et des compositions permettant de traiter des troubles associés à la lymphangiogenèse à l'aide d'inhibiteurs de VAP-1.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)